Global Continuous Subcutaneous Insulin Therapy Devices Market 2019-2023|Industry Analysis and Forecast| Technavio

Ad blocking detected

Thank you for visiting CanadianInsider.com. We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). Private browsing Firefox users should be able to disable tracking protection while visiting our website. Visit Mozilla support for more information. If you do not believe you have any ad-blocking software on your browser, you may want to try another browser, computer or internet service provider. Alternatively, you may consider the following if you want an ad-free experience.

Canadian Insider Ultra Club
$500/ year*
Daily Morning INK newsletter
+3 months archive
Canadian Market INK weekly newsletter
+3 months archive
30 publication downloads per month from the PDF store
Top 20 Gold, Top 30 Energy, Top 40 Stock downloads from the PDF store
All benefits of basic registration
No 3rd party display ads
JOIN THE CLUB

* Price is subject to applicable taxes.

Paid subscriptions and memberships are auto-renewing unless cancelled (easily done via the Account Settings Membership Status page after logging in). Once cancelled, a subscription or membership will terminate at the end of the current term.

Dec 11, 2018 09:48 am
LONDON -- 

Technavio’s global continuous subcutaneous insulin therapy devices (CSITD) market research report forecasts the market to grow at a CAGR of over 9% during the forecast period.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20181211005562/en/

Technavio has released a new market research report on the global continuous subcutaneous insulin th ...

Technavio has released a new market research report on the global continuous subcutaneous insulin therapy devices market for the period 2019-2023. (Graphic: Business Wire)

The rise in strategic partnerships will be one of the major trends in the global continuous subcutaneous insulin therapy devices market during 2019-2023. The vendors have been entering into strategic partnerships for integration of available and emerging technologies into their products. For instance, Medtronic entered into a collaboration with BD in June 2015. Under this collaboration, Medtronic will utilize BD FlowSmart technology in the development of an infusion set for CSITD.

This report is available at a USD 1,000 discount for a limited time only: View market snapshot before purchasing

According to Technavio analysts, one of the key drivers for the global continuous subcutaneous insulin therapy devices market is the rise in awareness about diabetes:

Global continuous subcutaneous insulin therapy devices market: Rise in awareness about diabetes

The rise in the prevalence of diabetes has resulted in increasing awareness efforts by various organizations across the globe. For instance, IDF is a type of umbrella organization that has over 240 national diabetes associations that are spread across 168 countries and territories around the globe. It has been working for raising awareness about diabetes from 1950 with a mission to enhance awareness about diabetes care and prevention globally.

According to a senior research analyst at Technavio, “The CDC runs diabetes prevention programs for reducing new cases of diabetes in the US. For instance, the CDC's Division of Diabetes Translation funds state and local health departments for supporting programs and activities for preventing or delaying the onset of type 2 diabetes, and for enhancing the health of people diagnosed with diabetes.”

Global continuous subcutaneous insulin therapy devices market: Segmentation analysis

This global continuous subcutaneous insulin therapy devices market analysis report provides market segmentation by product (tethered and patch) and by region (the Americas, APAC, and EMEA). This report provides an in-depth analysis of the prominent factors influencing the market, including drivers, opportunities, trends, and industry-specific challenges.

Of the two major products, the tethered segment held the largest continuous subcutaneous insulin therapy devices market share in 2018, contributing to about 70% of the market. This product segment will dominate the global market throughout the forecast period.

The Americas held the largest share of the market in 2018, accounting for around 44% share. It was followed by EMEA and APAC respectively. The Americas is expected to dominate the market throughout the period 2019-2023.

Looking for more information on this market? Request a free sample report

Technavio’s sample reports are free of charge and contain multiple sections of the report such as the market size and forecast, drivers, challenges, trends, and more.

Some of the key topics covered in the report include:

Market Landscape

  • Market ecosystem
  • Market characteristics
  • Market segmentation analysis

Market Sizing

  • Market definition
  • Market size and forecast

Five Forces Analysis

Market Segmentation

Geographical Segmentation

  • Regional comparison
  • Key leading countries

Market Drivers

Market Challenges

Market Trends

Vendor Landscape

  • Vendors covered
  • Vendor classification
  • Market positioning of vendors
  • Competitive scenario

About Technavio

Technavio is a leading global technology research and advisory company. Their research and analysis focuses on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions.

With over 500 specialized analysts, Technavio’s report library consists of more than 10,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio’s comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.

If you are interested in more information, please contact our media team at [email protected].

Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
www.technavio.com

Comment On!

140
Upload limit is up to 1mb only
To post messages to your Socail Media account, you must first give authorization from the websites. Select the platform you wish to connect your account to CanadianInsider.com (via Easy Blurb).